[go: up one dir, main page]

WO2002055680A3 - Morphometrisches gewebe- oder zellpräparat - Google Patents

Morphometrisches gewebe- oder zellpräparat Download PDF

Info

Publication number
WO2002055680A3
WO2002055680A3 PCT/EP2001/015055 EP0115055W WO02055680A3 WO 2002055680 A3 WO2002055680 A3 WO 2002055680A3 EP 0115055 W EP0115055 W EP 0115055W WO 02055680 A3 WO02055680 A3 WO 02055680A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell preparation
tissue
morphometric
cultivated
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/015055
Other languages
English (en)
French (fr)
Other versions
WO2002055680A2 (de
Inventor
Carolin Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to JP2002556729A priority Critical patent/JP2004520034A/ja
Priority to EP01985910A priority patent/EP1350101A2/de
Priority to US10/250,782 priority patent/US20040072281A1/en
Priority to AU2002235799A priority patent/AU2002235799A1/en
Publication of WO2002055680A2 publication Critical patent/WO2002055680A2/de
Publication of WO2002055680A3 publication Critical patent/WO2002055680A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die Erfindung betrifft ein morphometrisches Gewebe- oder Zellpräparat welches erhältlich ist, indem die folgenden Verfahrenstufen ausgeführt werden: a) Zellen oder Gewebe werden über eine definierte Zeit unter definierten Bedingungen in einer dreidimensionalen Matrix kultiviert, b) nach Ablauf der definierten Zeit wird die die kultivierten Zellen oder Gewebe enthaltende Matrix mit einer Fixier- und Färbelösung enthaltend ein Aldehyd sowie ein antigenunspezifisches Färbemittel inkubiert.
PCT/EP2001/015055 2001-01-09 2001-12-20 Morphometrisches gewebe- oder zellpräparat Ceased WO2002055680A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2002556729A JP2004520034A (ja) 2001-01-09 2001-12-20 形態測定用組織又は細胞調製物
EP01985910A EP1350101A2 (de) 2001-01-09 2001-12-20 Morphometrisches gewebe- oder zellpräparat
US10/250,782 US20040072281A1 (en) 2001-01-09 2001-12-20 Morphometric tissue or cell preparation
AU2002235799A AU2002235799A1 (en) 2001-01-09 2001-12-20 Morphometric tissue or cell preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10101319A DE10101319A1 (de) 2001-01-09 2001-01-09 Morphometrisches Gewebe- oder Zellpräparat
DE10101319.1 2001-01-09

Publications (2)

Publication Number Publication Date
WO2002055680A2 WO2002055680A2 (de) 2002-07-18
WO2002055680A3 true WO2002055680A3 (de) 2002-10-31

Family

ID=7670432

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/015055 Ceased WO2002055680A2 (de) 2001-01-09 2001-12-20 Morphometrisches gewebe- oder zellpräparat

Country Status (6)

Country Link
US (1) US20040072281A1 (de)
EP (1) EP1350101A2 (de)
JP (1) JP2004520034A (de)
AU (1) AU2002235799A1 (de)
DE (1) DE10101319A1 (de)
WO (1) WO2002055680A2 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268093A1 (de) * 1986-10-21 1988-05-25 Knoll Ag 5-Nitrobenzo[de]isochinolin-1,3-dione, ihre Herstellung und Verwendung
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide
WO1998006390A1 (de) * 1996-08-13 1998-02-19 Marigen S.A. Spontan dispergierbare konzentrate mit antiviral, viruzid und/oder antiparasitisch wirksamen estern von sterolen und vitamin-d-derivaten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5069374A (de) * 1973-10-24 1975-06-10
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268093A1 (de) * 1986-10-21 1988-05-25 Knoll Ag 5-Nitrobenzo[de]isochinolin-1,3-dione, ihre Herstellung und Verwendung
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide
WO1998006390A1 (de) * 1996-08-13 1998-02-19 Marigen S.A. Spontan dispergierbare konzentrate mit antiviral, viruzid und/oder antiparasitisch wirksamen estern von sterolen und vitamin-d-derivaten

Also Published As

Publication number Publication date
US20040072281A1 (en) 2004-04-15
DE10101319A1 (de) 2002-07-18
EP1350101A2 (de) 2003-10-08
AU2002235799A1 (en) 2002-07-24
WO2002055680A2 (de) 2002-07-18
JP2004520034A (ja) 2004-07-08

Similar Documents

Publication Publication Date Title
WO2002029600A3 (de) Zellenarordnung mit segmentierterwischenzellstruktur
AU2831000A (en) Electrolytic membrane for fuel cell and its manufacturing method, and fuel cell and its manufacturing method
WO2004053096A3 (en) Engineering three-dimensional tissue structures using differentiating embryonic stem cells
AU2001260071A1 (en) Method for producing a solar cell, and solar cell produced according to said method
WO2000031237A3 (en) Method of cloning porcine animals
DE69942185D1 (de) BODIPY Aminoacetaldehyd Diethyl Acetal
WO2001090345A3 (en) Methods and compositions for enhancing the delivery of a nucleic acid to a cell
DK1252324T3 (da) Solventfri ekstraktionsfremgangsmåde
WO2003020931A3 (en) Sirna knockout assay method and constructs
AU2001260067A1 (en) Method for producing a solar cell, and solar cell
WO2006129312A3 (en) Automated cell therapy system
AU2002225997A1 (en) Two chamber cell culture vessel
WO2003080816A3 (en) Stem cell culture
WO2003064630A3 (en) Cell culture medium
HK1052198A1 (zh) 超显示丙酮酸盐羧酶或丙酮酸盐磷烯醇丙酮酸盐羧酶的代谢工程细胞，及产生及使用该等细胞的方法
AUPR435101A0 (en) Further additions to the modified proton electrolytic membrane fuel cell
WO2000029551A3 (en) Cells, culture methods, and their use in autologous transplantation therapy
AU2001292318A1 (en) Fuel cell and production method therefor
WO1999002669A3 (en) Production of polyketides in plants
WO2002055680A3 (de) Morphometrisches gewebe- oder zellpräparat
HK1040420A1 (zh) 新陳代謝的選擇方法
EP1229111A3 (de) Kultivierte Zellen aus Ficus stipulata thunb. (= Ficus thunbergii) und ein Verfahren zur Züchtung von Ficus stipulata Geweben unter Verwendung dieser kultivierten Zellen
WO2002040645A3 (de) Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung
GB0229261D0 (en) Cells,culture methods and their uses
AU2002225011A1 (en) Method for improving the water balance of fuel cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001985910

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002556729

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2001985910

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10250782

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001985910

Country of ref document: EP